PDF⋙ Challenges for the FDA: The Future of Drug Safety, Workshop Summary (Forum on Drug Discovery, Development, and Translation) by Institute of Medicine, Board on Health Sciences Policy, Development, and Translation Forum on Drug Discovery, Sally Robinson, Leslie Pray

Challenges for the FDA: The Future of Drug Safety, Workshop Summary (Forum on Drug Discovery, Development, and Translation) by Institute of Medicine, Board on Health Sciences Policy, Development, and Translation Forum on Drug Discovery, Sally Robinson, Leslie Pray

Challenges for the FDA: The Future of Drug Safety, Workshop Summary (Forum on Drug Discovery, Development, and Translation) by Institute of Medicine, Board on Health Sciences Policy, Development, and Translation Forum on Drug Discovery, Sally Robinson, Leslie Pray PDF, ePub eBook D0wnl0ad

As the principal agency regulating food, drugs, medical devices, and biological products used by Americans, the U.S. Food and Drug Administration (FDA) serves one of the most critical consumer protection functions of the federal government. The FDA's reach is enormous, regulating products that represent roughly 25 percent of all consumer spending in the United States. Since 1992, however, federal funding for the agency has diminished, and the FDA's Center for Drug Evaluation and Research (CDER) currently relies on the fees it receives from the industry it regulates to fund the majority of its drug regulation functions. Prescription drug safety is receiving heightened press coverage and congressional scrutiny as a result of recent, highly publicized events, such as the recall of Vioxx because of its link to heart attacks, and the link between certain antidepressants (selective serotonin reuptake inhibitors, or SSRIs) and an increased risk of suicidal ideation in children.

To address these concerns, the FDA in 2005 commissioned the Institute of Medicine (IOM) to conduct an independent assessment of the current U.S. drug safety system. In September 2006, the IOM committee released its report-The Future of Drug Safety: Promoting and Protecting the Health of the Public-which included 25 recommendations for improving the system for drug safety review. The committee identified four major vulnerabilities in the U.S. drug safety system: (1) chronic underfunding; (2) organization problems, particularly inadequate integration of pre-and postmarket data review; (3) a range of technical problems related to the insufficient quantity and quality of postmarket data and inadequate capability to systematically monitor the risks and benefits of drugs after marketing; and (4) unclear regulatory authority and insufficiently flexible regulatory tools. Since the IOM report was issued, the FDA has taken a number of steps toward implementing the recommended improvements. Like many government agencies, however, the FDA is financially strained by its existing responsibilities, and fully implementing the recommended improvements to the drug safety system would require significant financial commitments.The IOM report addressed some of the costs associated with its recommendations, but left many unanswered questions about the resources required to fully achieve the envisioned improvements. To better understand the types and magnitude of resources required to achieve the goals of the IOM report, the IOM's Forum on Drug Discovery, Development, and Translation convened a 1-day symposium in March 2007.

Challenges for the FDA: The Future of Drug Safety, Workshop Summary explains the presentations and discussions in seven key areas: addressing the FDA's resource challenges; strengthening the scientific base of the agency; integrating pre- and postmarket review; enhancing postmarket safety monitoring; conducting confirmatory drug safety and efficacy studies; enhancing the value of clinical trial registration; and enhancing the FDA's postmarket regulation and enforcement.

From reader reviews:

Lindsey Gant:

Reading a publication can be one of a lot of pastime that everyone in the world adores. Do you like reading book consequently. There are a lot of reasons why people love it. First reading a guide will give you a lot of new data. When you read a publication you will get new information mainly because book is one of many ways to share the information or their idea. Second, examining a book will make you more imaginative. When you studying a book especially fictional works book the author will bring you to imagine the story how the personas do it anything. Third, you can share your knowledge to some others. When you read this Challenges for the FDA: The Future of Drug Safety, Workshop Summary (Forum on Drug Discovery, Development, and Translation), you may tells your family, friends along with soon about yours guide. Your knowledge can inspire the mediocre, make them reading a guide.

Mario Berry:

Are you kind of stressful person, only have 10 or even 15 minute in your day time to upgrading your mind expertise or thinking skill possibly analytical thinking? Then you are having problem with the book when compared with can satisfy your short space of time to read it because this time you only find reserve that need more time to be go through. Challenges for the FDA: The Future of Drug Safety, Workshop Summary (Forum on Drug Discovery, Development, and Translation) can be your answer because it can be read by anyone who have those short spare time problems.

June Whitaker:

A lot of book has printed but it differs from the others. You can get it by internet on social media. You can choose the most effective book for you, science, comic, novel, or whatever through searching from it. It is identified as of book Challenges for the FDA: The Future of Drug Safety, Workshop Summary (Forum on Drug Discovery, Development, and Translation). You can contribute your knowledge by it. Without leaving the printed book, it could possibly add your knowledge and make anyone happier to read. It is most essential that, you must aware about guide. It can bring you from one place to other place.

Read Challenges for the FDA: The Future of Drug Safety, Workshop Summary (Forum on Drug Discovery, Development, and Translation) by Institute of Medicine, Board on Health Sciences Policy, Development, and Translation Forum on Drug Discovery, Sally Robinson, Leslie Pray for online ebook

Challenges for the FDA: The Future of Drug Safety, Workshop Summary (Forum on Drug Discovery, Development, and Translation) by Institute of Medicine, Board on Health Sciences Policy, Development, and Translation Forum on Drug Discovery, Sally Robinson, Leslie Pray Free PDF d0wnl0ad, audio books, books to read, good books to read, cheap books, good books, online books, books online, book reviews epub, read books online, books to read online, online library, greatbooks to read, PDF best books to read, top books to read Challenges for the FDA: The Future of Drug Safety, Workshop Summary (Forum on Drug Discovery, Development, and Translation) by Institute of Medicine, Board on Health Sciences Policy, Development, and Translation Forum on Drug Discovery, Sally Robinson, Leslie Pray books to read online.

Challenges for the FDA: The Future of Drug Safety, Workshop Summary (Forum on Drug Discovery, Development, and Translation) by Institute of Medicine, Board on Health Sciences Policy, Development, and Translation Forum on Drug Discovery, Sally Robinson, Leslie Pray Doc

Challenges for the FDA: The Future of Drug Safety, Workshop Summary (Forum on Drug Discovery, Development, and Translation) by Institute of Medicine, Board on Health Sciences Policy, Development, and Translation Forum on Drug Discovery, Sally Robinson, Leslie Pray Mobipocket

Challenges for the FDA: The Future of Drug Safety, Workshop Summary (Forum on Drug Discovery, Development, and Translation) by Institute of Medicine, Board on Health Sciences Policy, Development, and Translation Forum on Drug Discovery, Sally Robinson, Leslie Pray EPub